Cargando…
Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation
BACKGROUND: Hypertrophy (H) is an adaptive response of the heart to a hemodynamic overload. Severe left ventricular (LV) volume overload (VO) from valve regurgitations (aortic (AR) or mitral regurgitation) leads to eccentric LVH. Increased protein turnover is a major event during development of LVH...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542859/ https://www.ncbi.nlm.nih.gov/pubmed/26306297 http://dx.doi.org/10.1186/s40064-015-1230-1 |
_version_ | 1782386563910467584 |
---|---|
author | Drolet, Marie-Claude Desbiens-Brassard, Vincent Roussel, Elise Tu, Veronique Couet, Jacques Arsenault, Marie |
author_facet | Drolet, Marie-Claude Desbiens-Brassard, Vincent Roussel, Elise Tu, Veronique Couet, Jacques Arsenault, Marie |
author_sort | Drolet, Marie-Claude |
collection | PubMed |
description | BACKGROUND: Hypertrophy (H) is an adaptive response of the heart to a hemodynamic overload. Severe left ventricular (LV) volume overload (VO) from valve regurgitations (aortic (AR) or mitral regurgitation) leads to eccentric LVH. Increased protein turnover is a major event during development of LVH and the mechanistic target of rapamycin (mTOR) is a key molecule for its control. The role of mTOR inhibition in the development of LVH using rapamycin for relatively short periods of time (days to a few weeks) has been studied in the past in pressure overload models but not in VO models. We investigated if mTOR pathway was activated during LVH development in a model of severe VO (AR) in rats and if a rapamycin treatment can slow heart remodeling in this situation. METHODS AND RESULTS: Male rats with severe AR were studied acutely at 2 days, at 8 weeks (compensated phase) and 6 months (late phase) after VO induction. mTOR complex (mTORC) 1 (ribosomal S6 protein phosphorylation) was activated early after AR induction but not later in the disease whereas mTORC2 activity levels (Akt phosphorylation at Ser473) remained stable. We observed that a moderate dose of rapamycin (2 mg/kg/day; orally) for 8 weeks prevented severe LVH caused by AR (−46 %: p < 0.001). Rapamycin treatment specifically inhibited LV mTORC1 without altering mTORC2 activity at 8 weeks. Rapamycin also prevented cardiac myocyte hypertrophy caused by AR. CONCLUSION: Rapamycin slows hypertrophy in LV VO by inhibiting early activation of mTORC1 without modulating mTORC2. |
format | Online Article Text |
id | pubmed-4542859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-45428592015-08-24 Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation Drolet, Marie-Claude Desbiens-Brassard, Vincent Roussel, Elise Tu, Veronique Couet, Jacques Arsenault, Marie Springerplus Research BACKGROUND: Hypertrophy (H) is an adaptive response of the heart to a hemodynamic overload. Severe left ventricular (LV) volume overload (VO) from valve regurgitations (aortic (AR) or mitral regurgitation) leads to eccentric LVH. Increased protein turnover is a major event during development of LVH and the mechanistic target of rapamycin (mTOR) is a key molecule for its control. The role of mTOR inhibition in the development of LVH using rapamycin for relatively short periods of time (days to a few weeks) has been studied in the past in pressure overload models but not in VO models. We investigated if mTOR pathway was activated during LVH development in a model of severe VO (AR) in rats and if a rapamycin treatment can slow heart remodeling in this situation. METHODS AND RESULTS: Male rats with severe AR were studied acutely at 2 days, at 8 weeks (compensated phase) and 6 months (late phase) after VO induction. mTOR complex (mTORC) 1 (ribosomal S6 protein phosphorylation) was activated early after AR induction but not later in the disease whereas mTORC2 activity levels (Akt phosphorylation at Ser473) remained stable. We observed that a moderate dose of rapamycin (2 mg/kg/day; orally) for 8 weeks prevented severe LVH caused by AR (−46 %: p < 0.001). Rapamycin treatment specifically inhibited LV mTORC1 without altering mTORC2 activity at 8 weeks. Rapamycin also prevented cardiac myocyte hypertrophy caused by AR. CONCLUSION: Rapamycin slows hypertrophy in LV VO by inhibiting early activation of mTORC1 without modulating mTORC2. Springer International Publishing 2015-08-20 /pmc/articles/PMC4542859/ /pubmed/26306297 http://dx.doi.org/10.1186/s40064-015-1230-1 Text en © Drolet et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Drolet, Marie-Claude Desbiens-Brassard, Vincent Roussel, Elise Tu, Veronique Couet, Jacques Arsenault, Marie Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation |
title | Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation |
title_full | Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation |
title_fullStr | Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation |
title_full_unstemmed | Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation |
title_short | Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation |
title_sort | blockade of the acute activation of mtor complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542859/ https://www.ncbi.nlm.nih.gov/pubmed/26306297 http://dx.doi.org/10.1186/s40064-015-1230-1 |
work_keys_str_mv | AT droletmarieclaude blockadeoftheacuteactivationofmtorcomplex1decreaseshypertrophydevelopmentinratswithsevereaorticvalveregurgitation AT desbiensbrassardvincent blockadeoftheacuteactivationofmtorcomplex1decreaseshypertrophydevelopmentinratswithsevereaorticvalveregurgitation AT rousselelise blockadeoftheacuteactivationofmtorcomplex1decreaseshypertrophydevelopmentinratswithsevereaorticvalveregurgitation AT tuveronique blockadeoftheacuteactivationofmtorcomplex1decreaseshypertrophydevelopmentinratswithsevereaorticvalveregurgitation AT couetjacques blockadeoftheacuteactivationofmtorcomplex1decreaseshypertrophydevelopmentinratswithsevereaorticvalveregurgitation AT arsenaultmarie blockadeoftheacuteactivationofmtorcomplex1decreaseshypertrophydevelopmentinratswithsevereaorticvalveregurgitation |